Euro-Med Laboratories Philippines (PHS:EURO) PS Ratio: 0.68 (As of Jul. 10, 2026) — 25% Below Median


PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
85 GF Score
Price ₱1.09
GF Value ₱1.03
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines PS Ratio?

Euro-Med Laboratories Philippines PHS:EURO +4.81% 85 PS Ratio is 0.68 as of Jul. 10, 2026, which is 25% below its 10-year median of 0.91. GuruFocus rates PHS:EURO with a GF Score™ of 85/100 and a GF Value™ of ₱1.03 (Fairly Valued). The stock has 7 warning signs investors should review. Among 952 Drug Manufacturers companies, Euro-Med Laboratories Philippines ranks better than 83.3% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Euro-Med Laboratories Philippines's share price is ₱1.09. Euro-Med Laboratories Philippines's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₱1.59. Hence, Euro-Med Laboratories Philippines's PS Ratio for today is 0.68.

Warning Sign:

Euro-Med Laboratories Philippines Inc stock PS Ratio (=0.69) is close to 3-year high of 0.75.

The historical rank and industry rank for Euro-Med Laboratories Philippines's PS Ratio or its related term are showing as below:

PHS:EURO' s PS Ratio Range Over the Past 10 Years
Min: 0.47   Med: 0.91   Max: 6.69
Current: 0.68

During the past 13 years, Euro-Med Laboratories Philippines's highest PS Ratio was 6.69. The lowest was 0.47. And the median was 0.91.

PHS:EURO's PS Ratio is ranked better than
83.3% of 952 companies
in the Drug Manufacturers industry
Industry Median: 2.295 vs PHS:EURO: 0.68

Euro-Med Laboratories Philippines's Revenue per Sharefor the three months ended in Mar. 2026 was ₱0.39. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₱1.59.

Warning Sign:

Euro-Med Laboratories Philippines Inc revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Euro-Med Laboratories Philippines was -0.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 17.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 14.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.90% per year.

During the past 13 years, Euro-Med Laboratories Philippines's highest 3-Year average Revenue per Share Growth Rate was 17.60% per year. The lowest was -11.70% per year. And the median was 2.50% per year.

Back to Basics: PS Ratio


Euro-Med Laboratories Philippines  (PHS:EURO) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Euro-Med Laboratories Philippines PS Ratio Related Terms


Euro-Med Laboratories Philippines PS Ratio Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines PS Ratio Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 0.85 0.59 0.58 0.60

Euro-Med Laboratories Philippines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.58 0.61 0.60 0.63

PHS:EURO vs ZTS, UTHR, VTRS: PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euro-Med Laboratories Philippines PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's PS Ratio distribution charts can be found below:

* The bar in red indicates where Euro-Med Laboratories Philippines's PS Ratio falls into.


PHS:EURO
85GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euro-Med Laboratories Philippines PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Euro-Med Laboratories Philippines's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.09/1.594
=0.68

Euro-Med Laboratories Philippines's Share Price of today is ₱1.09.
Euro-Med Laboratories Philippines's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱1.59.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 0.68 mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a PS Ratio of 0.68 as of Jul. 10, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 25% below median its historical median of 0.91. Over the past decade, Euro-Med Laboratories Philippines' PS Ratio has ranged from 0.47 to 6.69. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #159 out of 952 companies in the Drug Manufacturers industry, placing it in the top 16.7%.
Is Euro-Med Laboratories Philippines' PS Ratio too high?
Euro-Med Laboratories Philippines' current PS Ratio of 0.68 is 25% below median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 6.69. The Drug Manufacturers industry median PS Ratio is 2.30. Euro-Med Laboratories Philippines' value of 0.68 is 70.4% below this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #159 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #159 out of 952 companies for PS Ratio. This places Euro-Med Laboratories Philippines in the top 17% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.30. Euro-Med Laboratories Philippines' value of 0.68 is 70.4% below this benchmark. Historically, Euro-Med Laboratories Philippines' own PS Ratio has ranged from 0.47 to 6.69 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 2.30, Euro-Med Laboratories Philippines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current PS Ratio of 0.68 is 70.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current PS Ratio is 0.68, which is 25% below median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.03, compared to a current price of ₱1.09 — trading 5.8% above its estimated fair value. The current PS Ratio is 0.68, which is 25% below median its 10-year median of 0.91 and 70.4% below the Drug Manufacturers industry median of 2.30. Euro-Med Laboratories Philippines' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current PS Ratio is 0.68 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.09 is trading 5.8% above its estimated GF Value™ of ₱1.03. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • PS Ratio: 0.68 (25% below median its 10-year median of 0.91)
  • GF Value™: ₱1.03 vs. price of ₱1.09 (5.8% above fair value)
  • GF Score™: 85/100 with 7 warning signs
  • Industry Position: 70.4% below the Drug Manufacturers median (#159 of 952)

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
85GF Score

Get the complete analysis for PHS:EURO

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.09
Price
₱1.03
GF Value